New ver­sion of Sero­quel OKd

Los Angeles Times - - Business -

As­traZeneca said U.S. reg­u­la­tors had ap­proved a new on­cedaily ver­sion of its Sero­quel schizophre­nia drug.

Sero­quel is the Lon­don­based com­pany’s sec­ond-big­gest-sell­ing drug, with global sales of $3.4 bil­lion last year. An­a­lysts said Food and Drug Ad­min­is­tra­tion ap­proval of Sero­quel XR was im­por­tant to ex­tend the life cy­cle of the fam­ily of drugs.

The new ver­sion of the drug is un­der pa­tent un­til 2017.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.